Protocol for the reporting assessment of clinical trials with non-pharmacological therapies in Chinese medicine
Hanzhi Tan(Hong Kong Baptist University), Xuan Zhang(Hong Kong Baptist University), Chung Wah Cheng(Hong Kong Baptist University), Jiashuai Deng(Beijing University of Chinese Medicine), Zhaoxiang Bian(Hong Kong Baptist University), Ping Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yalin Jiao(Beijing University of Chinese Medicine), Juan Wang(Sun Yat-sen University), Nana Wang(Guang’anmen Hospital), Ji Li(Jinzhou Medical University), Han Li(Liuzhou General Hospital), Dongni Shi(Hong Kong Baptist University), Fei Han(Hangzhou Center for Disease Control and Prevention)
Cited by 2
Related Papers
Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
|Nature Communications|2016|597
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
|Nature Communications|2020|478
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
|Nature Medicine|2015|355
Beta-glucans from edible and medicinal mushrooms: Characteristics, physicochemical and biological activities
|Journal of Food Composition and Analysis|2015|301